ATE543906T1 - Antigen von streptococcus aus der b-gruppe - Google Patents

Antigen von streptococcus aus der b-gruppe

Info

Publication number
ATE543906T1
ATE543906T1 AT03701402T AT03701402T ATE543906T1 AT E543906 T1 ATE543906 T1 AT E543906T1 AT 03701402 T AT03701402 T AT 03701402T AT 03701402 T AT03701402 T AT 03701402T AT E543906 T1 ATE543906 T1 AT E543906T1
Authority
AT
Austria
Prior art keywords
streptococcus
group
antigen
epitopes
gbs
Prior art date
Application number
AT03701402T
Other languages
German (de)
English (en)
Inventor
Stephane Rioux
Denis Martin
Josee Hamel
Bernard Brodeur
Original Assignee
Id Biomedical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Id Biomedical Corp filed Critical Id Biomedical Corp
Application granted granted Critical
Publication of ATE543906T1 publication Critical patent/ATE543906T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Communicable Diseases (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT03701402T 2002-02-11 2003-02-11 Antigen von streptococcus aus der b-gruppe ATE543906T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35494702P 2002-02-11 2002-02-11
PCT/CA2003/000186 WO2003068813A2 (en) 2002-02-11 2003-02-11 Group b streptococcus antigen

Publications (1)

Publication Number Publication Date
ATE543906T1 true ATE543906T1 (de) 2012-02-15

Family

ID=27734441

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03701402T ATE543906T1 (de) 2002-02-11 2003-02-11 Antigen von streptococcus aus der b-gruppe

Country Status (8)

Country Link
US (1) US20070275004A1 (enExample)
EP (1) EP1472353B1 (enExample)
JP (1) JP2005535287A (enExample)
AT (1) ATE543906T1 (enExample)
AU (1) AU2003203097C1 (enExample)
CA (1) CA2475821C (enExample)
ES (1) ES2381967T3 (enExample)
WO (1) WO2003068813A2 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU228497B1 (en) 1998-02-20 2013-03-28 Id Biomedical Corp Quebec Group b steptococcus antigens
AU1412702A (en) 2000-10-27 2002-05-06 Chiron Spa Nucleic acids and proteins from streptococcus groups a and b
PT1648500E (pt) 2003-07-31 2014-10-10 Novartis Vaccines & Diagnostic Composições imunogénicas para estreptococos piogenes
US8945589B2 (en) 2003-09-15 2015-02-03 Novartis Vaccines And Diagnostics, Srl Immunogenic compositions for Streptococcus agalactiae
EP1784211A4 (en) 2004-07-29 2010-06-30 Novartis Vaccines & Diagnostic IMMUNOGENIC COMPOSITIONS FOR GRAMPOSITIVE BACTERIA SUCH AS STREPTOCOCCUS AGALACTIAE
JP2008530021A (ja) * 2005-02-08 2008-08-07 アイディー バイオメディカル コーポレイション オブ ケベック シー．オー．ビー． アズ グラクソスミスクライン バイオロジカルズ ノース アメリカ 医薬組成物
ES2310062B1 (es) * 2005-07-15 2009-11-13 Bionostra, S.L. Particulas pseudovirales vacias quimericas derivadas del virus causante de la enfermedad de la bursitis infecciosa (ibdv), procedimiento de obtencion y aplicaciones.
MX2010002773A (es) 2007-09-12 2010-03-31 Novartis Ag Antigenos mutantes de gas57 y anticuerpos de gas57.
CN103834669B (zh) * 2014-02-21 2016-06-29 通威股份有限公司 一种无乳链球菌的口服疫苗及其制备方法
CN107502622A (zh) * 2016-06-14 2017-12-22 广东省农业科学院动物卫生研究所 Sip基因重组载体、壳聚糖‑PLGA包裹Sip基因DNA疫苗及其制备方法和应用
GB2597569B (en) * 2018-06-13 2023-01-25 Gen Probe Inc Compositions and methods for detecting group B streptococcus nucleic acid

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5302386A (en) * 1986-04-16 1994-04-12 Brigham And Women's Hospital, Inc. Bacterial antigens, antibodies, vaccines and methods of manufacture
US5472696A (en) * 1988-02-26 1995-12-05 Univ. Of Florida Research Foundation, Inc. Antigen of group B streptococci
US5648241A (en) * 1989-09-15 1997-07-15 The General Hospital Corporation Conjugate vaccine against group B streptococcus
US5679768A (en) * 1991-02-15 1997-10-21 Uab Research Foundation Epitopic regions of pneumococcal surface protein A
US5225331A (en) * 1991-04-25 1993-07-06 National Research Council Of Canada Immunoassay for detecting group b streptococcus
JP3976334B2 (ja) * 1993-03-19 2007-09-19 リンダール， グンナル Ｂ群れんさ球菌の多くの菌株に対する免疫を与える細胞表面タンパク質であるタンパク質Ｒｉｂ、そのタンパク質の精製方法、薬剤キットおよび医薬組成物
US5595740A (en) * 1994-05-16 1997-01-21 University Of Florida Cloning of non-IgA FC binding forms of the group B streptococcal beta antigens
EP0754703A4 (en) * 1994-11-01 1999-11-24 Kirin Brewery PEPTIDE SEQUENCE FORMING A MUCIN CHAIN AND TECHNIQUE FOR MODIFYING THE PROTEIN TO BE LINKED TO THE MUCIN CHAIN
HU228497B1 (en) * 1998-02-20 2013-03-28 Id Biomedical Corp Quebec Group b steptococcus antigens
GB9921125D0 (en) * 1999-09-07 1999-11-10 Microbial Technics Limited Proteins

Also Published As

Publication number Publication date
CA2475821A1 (en) 2003-08-21
EP1472353B1 (en) 2012-02-01
US20070275004A1 (en) 2007-11-29
AU2003203097C1 (en) 2010-02-04
EP1472353A2 (en) 2004-11-03
AU2003203097A1 (en) 2003-09-04
WO2003068813A3 (en) 2003-10-16
AU2003203097B2 (en) 2009-10-01
JP2005535287A (ja) 2005-11-24
ES2381967T3 (es) 2012-06-04
CA2475821C (en) 2011-12-13
WO2003068813A2 (en) 2003-08-21

Similar Documents

Publication Publication Date Title
MA40801B2 (fr) Anticorps anti-cd3, anticorps anti-cd123 et anticorps bispécifiques se liant spécifiquement à cd3 et/ou cd123
GEP20115333B (en) Antagonist antibodies directed against calcitonin generelated peptide and using same
UY28641A1 (es) Anticuerpos
IL195338A (en) An antibody comprising an FC variant containing amino acid replaces d or e at position 239, a medicament containing it and its use
MX338940B (es) Identificacion de epitopos ige novedosos.
DK1362109T3 (da) Rekombinante oligomere protein-komplekser med foröget immunogent potentiale
BG104149A (bg) Белтъци, свързващи интерлевкин-18, тяхното получаване и приложение
BRPI0506771A (pt) anticorpo, e, composição farmacêutica
DK1434791T3 (da) Specifikke bindingsmidler til human angiopoietin-2
NO20071192L (no) Varianter av FC-regioner.
ATE543906T1 (de) Antigen von streptococcus aus der b-gruppe
MX2022014852A (es) Métodos para tratar o prevenir infecciones por sars-cov-2 y covid-19 con anticuerpos de glicoproteína espícular anti-sars-cov-2.
ATE356206T1 (de) Menschliches krebsantigen ny eso-1/cag-3 und dazu kodierendes gen
ATE387629T1 (de) Gemeinsame epitope von antigenen aus einer multigen-familie
GB0008305D0 (en) Treatment of fungal infections
ATE537186T1 (de) P53-bindendes polypeptid
ATE477274T1 (de) Gegen clostridium difficile gerichtete antikörper
ATE453714T1 (de) Antigene aus cryptosporidium parvum, antikörper dagegen und diagnostische und therapeutische zusammensetzungen
BR0113099A (pt) Gene e proteìna relacionados com esquizofrenia
DK1368372T3 (da) Peptid med affinitet til det virale gp120-protein samt anvendelse deraf
EA200601743A1 (ru) Выделенный полипептид реналазы и его применение
EA200701870A1 (ru) Пептид, происходящий из вируса гепатита с
EA200400392A1 (ru) Связывающий каспазу-8 белок, его получение и применение
DE60235223D1 (de) Streptococcus pyogenes polypeptide und entsprechende dna fragmente
DE60234772D1 (de) Gruppe-b streptococcus antigene und entsprechende dna-fragmente